[Treatment strategy of type 2 diabetes used in Czech Republic after metformin therapy failure].

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Vnitrni lekarstvi

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 29127747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular Outcomes and Mortality in Type 2 Diabetes with Associated Cardio-Renal-Metabolic Comorbidities

  2018cited by this paper
• Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

  2016cited by this paper
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

  2016cited by this paper
• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

  2016cited by this paper
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

  2016cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2014cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes

  2012cited by this paper
• Standards of Medical Care in Diabetes—2011

  2011cited by this paper
• Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review

  2011cited by this paper
• Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

  2010cited by this paper
• From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

  2009cited by this paper
• Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?

  2008cited by this paper
• Nutrition Recommendations and Interventions for Diabetes

  2008cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006cited by this paper
• Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials

  2002cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper

• No citing papers are available for this paper.